We are excited to announce the addition of several new features to MedTRACK.
Once again we have expanded our coverage of the biomedical industry! We have launched an innovative Royalty Explorer tool that calculates royalties across products, companies and therapeutic areas. We have also enhanced our database by integrating analyst consensus estimates to our sales data and adding route of administration data to our products for advanced filtering options. More on all of these features below!
Royalty Explorer
Benchmark what other companies have paid or been paid for their products with MedTRACK’s new Royalty Explorer! This proprietary tool has been developed to aid in financial decision-making by analyzing disclosed royalty values of agreements within the life sciences. It will estimate royalty rates for products whose rates have not been publicly disclosed. The Royalty Explorer also assesses the costs and benefits of licensing a product or technology vs. bringing it to market unpartnered.
Subscribers have the ability to search by:
- Company name
- Product name
- Active Ingredient
- Disease hub
- Phase
- Geography
Information is segmented by:
- Product Name
- Active Ingredient
- Source
- Partner
- Disease Hub
- Deal Type
- Royalty Type (Disclosed/Undisclosed)
- Territories (Included/Excluded)
- Financial Details
Analyst Consensus Sales Forecasts
MedTRACK has expanded its coverage of product sales data to include Analyst Consensus Sales Forecasts. Along with historical data, the forecasts aid in investment decisions by providing insight into a company’s future revenue, impact of the competition and potential return on investment. With MedTRACK's wealth of competitive intelligence on product sales and growth, subscribers can develop models for determining potential market size and assessing the impact of market-affecting events such as regulatory approval and patent expirations.
Subscribers have the ability to search by:
- Product name
- Company
- Ticker symbol
- Disease hub
- Drug class
- MOA
- Indication
Route of Administration (ROA) Search
MedTRACK has added a new search filter to the Screener Tool, allowing users to filter products by specific routes of administration based on a standard list from the FDA. From drug discovery professionals to business development associates, subscribers can use this focused query option to further enhance product and market segmentation as they assess the competitive landscape.
|
